Login/Sign Up
Aggrilek Infusion
Aggrilek Infusion is used to Prevent blood clots, heart attacks, and chest pain. It contains Tirofiban, an antiplatelet that prevents platelets (blood cells) from sticking together to form blood clots. Thus, it is used to prevent blood clots. It also helps blood flow to the heart and prevents heart attack and chest pain. Additionally, it may be used in patients whose heart vessels are dilated with a balloon (percutaneous coronary intervention or PCI). It is intended for use with unfractionated heparin and aspirin.
₹3142.95*
MRP ₹3832.86
18% off
₹3257.93*
MRP ₹3832.86
15% CB
₹574.93 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Aggrilek Infusion belongs to a class of medicines called 'antiplatelets' (blood thinners) used to prevent blood clots. It helps to prevent heart attack and chest pain. It is intended for use with unfractionated heparin and aspirin. A blood clot is a clump of blood that has changed from a liquid to a gel-like or semisolid state. Blood clots are formed to stop bleeding that occurs due to tissue injury. Though blood clots are useful for stopping bleeding, they are harmful when abnormally formed within blood vessels as they block blood vessels and inhibit blood flow to essential organs such as the brain, heart, or lungs.
Aggrilek Infusion contains Tirofiban, a platelet aggregation inhibitor which works by preventing platelets (blood cells) from sticking together to form blood clots. Thus, it prevents blood clot formation.
Aggrilek Infusion will be administered by a healthcare professional; do not self-administer. Sometimes, Aggrilek Infusion may cause common side effects such as bleeding under the skin at the site of injection or into a muscle causing swelling, bleeding after surgery, invisible blood in stool or urine, headache or feeling sick. Most of these side effects of Aggrilek Infusion do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Tirofiban or any other medicines, please tell your doctor. Aggrilek Infusion is not recommended for children as safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, inform your doctor before receiving Aggrilek Infusion. Avoid alcohol consumption with Aggrilek Infusion as it may increase the risk of bleeding in the stomach or intestines. If you have a history of stroke or bleeding internally within the last 30 days, avoid receiving Aggrilek Infusion.
Aggrilek Infusion contains Tirofiban, an antiplatelet which prevents platelets (blood cells) from sticking together to form blood clots. Thus, it is used to prevent blood clots. Also, it helps blood flow to the heart and prevents heart attack and chest pain. Additionally, it may be used in patients whose heart vessels are dilated with a balloon (percutaneous coronary intervention or PCI). It is intended for use with unfractionated heparin and aspirin.
If you are allergic to Tirofiban or any other medicines, please tell your doctor. Aggrilek Infusion is not recommended for children as safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, inform your doctor before receiving Aggrilek Infusion. Avoid alcohol consumption with Aggrilek Infusion as it may increase the risk of bleeding in the stomach or intestines. If you have a history of stroke or bleeding internally within the last 30 days, avoid receiving Aggrilek Infusion. If you have had cardiopulmonary resuscitation (CPR), a biopsy, or a procedure to break up kidney stones within the last 2 weeks or have been seriously injured, had a major operation or had an ulcer in the stomach or intestine within the last 3 months, had a recent spinal procedure, have history or symptoms of aortic dissection (splitting of the aorta, main artery), or had a special intravenous line inserted under your collar bone within the last 24 hours, inform your doctor before receiving Aggrilek Infusion.
Drug-Drug Interaction: Inform your doctor if you are taking another blood thinner (warfarin) or are taking or have recently taken other medicines, including those obtained without a prescription.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: Avoid receiving Aggrilek Infusion if are bleeding internally, have severe uncontrolled high blood pressure, thrombocytopenia (low blood platelet count), have severe liver disease or have a history of stroke, bleeding in the brain, abnormal blood vessels in the brain or brain tumour. If you have anaemia (lack of blood), liver disorder, heart failure, kidney problems, vasculitis (inflammation of the blood vessels), uncontrolled high blood pressure, pericarditis (inflammation of the lining around your heart), bleeding disorder, cardiogenic shock (very low blood pressure due to a failing heart) or ulcer in the stomach or intestine, inform your doctor before receiving Aggrilek Infusion.
Blood clots: A blood clot is a clump of blood that has changed from a liquid to a gel-like or semisolid state. Blood clots are formed to stop bleeding that occurs due to tissue injury. Though blood clots are useful to stop bleeding, they may be harmful when abnormally formed within blood vessels as they block blood vessels and inhibit blood flow to essential organs such as the brain, heart, or lungs and result in serious conditions. The common risk factors for blood clots are obesity, smoking, cancer, family history of blood clots, aged over 65 years, certain birth control pills, or pregnancy. If you experience chest pressure, sudden shortness of breath, or difficulty in breathing, speaking, or seeing, please consult a doctor immediately, as these might be symptoms of blood clots. Quick medication is advised to reduce the risk of serious conditions due to blood clots.
Alcohol
Unsafe
You are recommended to avoid the consumption of alcohol with Aggrilek Infusion as it may increase the risk of bleeding in the stomach or intestines.
Pregnancy
Consult your doctor
Limited data is available on the effect of Aggrilek Infusion in pregnancy. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Aggrilek Infusion. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Consult your doctor
Limited data is available on the effect of Aggrilek Infusion on breastfeeding mothers. Hence, if you are a nursing mother, inform your doctor before receiving Aggrilek Infusion. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Not applicable
Due to your disease state, you will not be able to drive or operate machinery while receiving Aggrilek Infusion.
Liver
Caution
Aggrilek Infusion is not recommended if you have severe liver disease. Therefore, if you have any liver disorder, inform your doctor before receiving Aggrilek Infusion.
Kidney
Caution
If you have kidney disease/condition, inform your doctor before receiving Aggrilek Infusion. The dose may be adjusted in patients with severe kidney failure.
Children
Unsafe
Aggrilek Infusion is not recommended for children as the safety and effectiveness were not established.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes